… The first part of this review will deal with somatostatin receptor-based imaging, the second
part with somatostatin receptor-based … Somatostatin receptor-based radionuclide imaging …

… Neuroendocrine tumours (NET) are uncommon and may be localized in many … somatostatin
receptor scintigraphy (SRS). Recently, it has become possible to use somatostatin receptor …

… Somatostatin analogs for the diagnosis and therapy of neuroendocrine tumors (NETs) have
… Five somatostatin receptor subtypes have been identified and molecular mechanisms of …

… lung and bladder tumors. The aim of the study was to investigate to what extent endocrine
tumors bear specific SRIF receptors, whether such characteristics are limited to tumors from …

… Expression of somatostatin receptor types 1–5 in 81 cases of gastrointestinal and
pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase …

… A number of different tumors have receptors for somatostatin. We … , a somatostatin analogue,
for tumor localization in 42 patients with carcinoid tumors, pancreatic endocrine tumors, or …

… Somatostatin receptor (SSTR) imaging is widely used for guiding the management of
neuroendocrine tumor (NET) patients. Ga-DOTATATE approval by the US Food and Drug …

… tumour types and among tumours of the same type. The predominant expression of sst2
receptors on pancreatic endocrine or carcinoid tumours … the octapeptide somatostatin analogues …

… neuroendocrine tumors (NETs), particularly gastrointestinal (GI) and pancreatic endocrine
tumors… expression of somatostatin receptor (SSTR) subtypes in neuroendocrine carcinomas (…

… somatostatin receptor SSTR2; somatostatin analogues are the best therapeutic option for
functional neuroendocrine tumors … of somatostatin analogues stabilize tumor growth over long …